(range, 1-79 months) with a primary patency of 85.4%. Cumulative primary assisted and secondary patency was 92.6%. The femoral patch repair was the most frequent site of reintervention. Mortality was 34% overall during the study period with one death at 30 days.
IP205. Outcomes After Open Lower Extremity Revascularization in Patients With Chronic Kidney Disease
Vishnu Ambur, Peter Park, John Gaughan, Scott Golarz, Frank Schmieder, Paul S. Van Bemmelen, Eric Choi, Ravi Dhanisetty. Temple University School of Medicine, Philadelphia, PA Objectives: Patient selection for open lower extremity revascularization in patients with chronic kidney disease (CKD) remains a clinical challenge. This study investigated the impact of CKD on graft failure, postoperative complications, and mortality in patients undergoing lower extremity bypass for critical limb ischemia.
Methods: The National Surgical Quality Improvement Program database was queried for all patients with critical limb ischemia from 2012 to 2015 who underwent lower extremity bypass using the targeted vascular set. Glomerular filtration rate was calculated using the Chronic Kidney Disease Epidemiology Collaboration Study equation. CKD categories were determined from the National Kidney Foundation Kidney Disease Outcomes Quality Initiative staging criteria. Patients were classified into three groups: CKD stages <3 (mild-moderate CKD), CKD stages 4/5 (severe CKD), and hemodialysis (HD). Multivariable analysis was used to examine graft failure, mortality, and postoperative complications.
Results: The National Surgical Quality Improvement Program database identified 6978 patients who underwent infrainguinal lower extremity arterial bypass during the study period. Of these, 6101 patients (87.4%) had mild-moderate CKD, 327 patients (4.7%) had severe CKD, and 550 patients (7.9%) were on HD. Patients with severe CKD and on HD were more likely to have revascularization for tissue loss (54.9% vs 68.8% and 74.7%; P < .01). Patients with severe CKD and those on HD had higher rates of graft failure, mortality, postoperative myocardial infarction (MI), and rates of reoperation (Table I) Author Disclosures: V. Ambur: Nothing to disclose; E. Choi: Nothing to disclose; R. Dhanisetty: Nothing to disclose; J. Gaughan: Nothing to disclose; S. Golarz: Nothing to disclose; P. Park: Nothing to disclose; F. Schmieder: Nothing to disclose; P. S. Van Bemmelen: ACI Medical, Inc: consulting fees (eg, advisory boards).
IP207.
Recurrent Cystic Adventitial Disease of the Popliteal Artery: Case Report and Review of the Literature Objectives: Cystic adventitial disease (CAD) is an uncommon disease of arteries and veins. It affects the popliteal artery in >85% of reported cases. It is five times more common in men compared to women and commonly occurs in the fourth or fifth decades. Unlike other causes of intermittent claudication, CAD often occurs in the absence atherosclerotic disease or risk factors. The disease process leads to unilocular or multilocular mucin-filled cysts in the adventitia of the vessels, which ultimately results in arterial stenosis or thrombosis. There is limited information available regarding the incidence of and risk factors for recurrent CAD or its ideal management.
Methods: We report an unusual case of recurrent CAD in an elderly man and review the current available literature.
Results: The patient is a 77-year-old man previously treated for CAD with cyst excision and saphenous vein interposition reconstruction 5 years prior. His recurrence presented with symptoms of claudication and a new palpable popliteal fossa mass. Imaging with computed tomography angiography confirmed recurrent CAD with positional saphenous vein graft compression and effacement (Fig 1) . He was treated with surgical excision of the popliteal cyst through a posterior approach, resolving the extrinsic compression on the interposition vein graft (Fig  2) . Although his postoperative course was complicated by lymphatic leak and abscess requiring surgical drainage and antibiotics, his recovery was otherwise uncomplicated, and his claudication symptoms resolved immediately.
Conclusions: Popliteal CAD remains a rare cause of lower extremity claudication. Recurrence after primary surgical treatment of CAD remains exceedingly rare, but may present with similar symptoms. Surgical resection remains the most effective treatment.
Author Disclosures: S. Banipal: Nothing to disclose; S. Bendix: Nothing to disclose; T. Boules: Nothing to disclose; K. Nasra: Nothing to disclose.
IP209.
Through-Knee Amputation: A Feasible Alternative to Above-Knee Amputation Sungho Lim, Pegge Halandras, Bernadette Aulivola, Paul Crisostomo. Loyola University Medical Center, Maywood, Ill
Objectives: Through-knee amputation (TKA) is a rare type of amputation performed in <2% of all major lower extremity amputations in the United States. Despite biomechanical benefits on rehabilitation compared to above-knee amputation (AKA), TKA has largely been abandoned by vascular surgeons due to concerns for poor wound healing. The purpose of this study was to evaluate surgical outcomes of TKA.
Methods:
The American College of Surgery National Surgical Quality Improvement Program between 2005 and 2012 was queried using Current Procedural Terminology codes indicating AKA and TKA. Baseline characteristics were reviewed, and logistic regression analysis was performed to identify predictors of 30-day mortality. Propensity score matching was used to balance comorbidities between AKA and TKA. Operative variables and postoperative complications were compared between the groups.
Results: A total of 7469 AKA and 251 TKA patients were identified among 15,932 major lower extremity amputations. White race, chronic obstructive pulmonary disease, dyspnea, emergent operation, steroid use, myocardial infarction, congestive heart failure, high American Society of Anesthesiologists score, old age, preoperative sepsis or septic shock, and dialysis dependency were associated with 30-day mortality. Independent lifestyle and smoking (within 1 year) were protective against early death. Baseline comorbidities were balanced after 1:1 propensity score matching. Operative outcomes were similar in both groups. Wound infection (7.2% vs 11.2; P ¼ .16), dehiscence rate (1.2% vs 0.8%; P ¼ 1.0), and 30-day mortality (9.6% vs 11.2%; P ¼ .66) were comparable. Other outcome parameters, AKA, Above-knee amputation; SD, standard deviation; TKA, throughknee amputation. a Days from operation to discharge. 
